Press release
Deadline on Sept. 26th coming up in Lawsuit for certain investors in shares of Syneos Health, Inc. (NASDAQ: SYNH)
A Deadline is coming up on September 25, 2023 in the lawsuit for certain investors in Syneos Health, Inc. (NASDAQ: SYNH).
Investors who purchased shares of Syneos Health, Inc. (NASDAQ: SYNH) have certain options and there are strict and short deadlines running. Deadline: September 25, 2023. NASDAQ: SYNH stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of Syneos Health, Inc. (NASDAQ: SYNH) common shares between September 9, 2020 and November 3, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between September 9, 2020 and November 3, 2022, the defendants made false and/or misleading statements and/or failed to disclose that Syneos' business development capabilities had been materially impaired by workforce reductions and leadership and operational changes, as well as labor force turmoil caused by the COVID-19 pandemic, that Syneos had struggled to integrate recent acquisitions, causing Syneos to suffer from a bloated and confused organizational structure and impairing Syneos' ability to provide comprehensive or effective customer engagement across its product portfolio, that Syneos was suffering from acute competitive disadvantages as clinical trials moved to remote monitoring and decentralized administration, as Syneos lacked the tools possessed by some of its rivals to successfully run remote and decentralized trials, such as certain data visualization and statistical modeling capabilities, and Syneos had failed to adapt to changing business demands in the wake of the COVID-19 pandemic, that Syneos' backlog, book-to-bill ratios, and net new business awards had been artificially inflated by more than $500 million through the inclusion of reimbursable expenses that Syneos would never collect, that as a result of the above, Syneos was struggling to execute on its existing contracts and to agilely respond to its client needs, causing Syneos to suffer client dissatisfaction across its client base, and that consequently, Syneos was exposed to a material undisclosed risk that Syneos would lose customers, be unable to grow its client base or win significant contract renewals, and cede market share to its rivals.
Those who purchased shares of Syneos Health, Inc. (NASDAQ: SYNH) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on Sept. 26th coming up in Lawsuit for certain investors in shares of Syneos Health, Inc. (NASDAQ: SYNH) here
News-ID: 3207447 • Views: …
More Releases from Shareholders Foundation
Lawsuit filed for Investors who lost money with shares of Enphase Energy, Inc. ( …
An investor, who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH), filed a lawsuit over alleged violations of Federal Securities Laws by Enphase Energy, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH) have certain options and for certain investors are short and strict deadlines running. Deadline: April 20, 2026. NASDAQ: ENPH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation announced for Long-Term Investors in shares of Fiserv, Inc. (NYSE: …
An investigation was announced for current long-term investors in shares of Fiserv, Inc. (NYSE: FI) concerning potential breaches of fiduciary duties by certain directors and officers of Fiserv, Inc.
Investors who are current long term investors in Fiserv, Inc. (NYSE: FI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Ardent Health, Inc. (NYSE: ARDT) Investor Alert: Deadline in Lawsuit on March 09 …
A deadline is coming up on March 09, 2026 in the lawsuit filed for certain investors of Ardent Health, Inc. (NYSE: ARDT) over alleged securities laws violations by Ardent Health, Inc.
Investors who purchased shares of Ardent Health, Inc. (NYSE: ARDT) have certain options and there are strict and short deadlines running. Deadline: March 09, 2026. Ardent Health, Inc. (NYSE: ARDT) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
Sina Corporation (formerly NASDAQ: SINA) Investor Alert: Investigation of potent …
An investigation on behalf of investors in shares of Sina Corporation (formerly NASDAQ: SINA) concerning potential breaches of fiduciary duties by certain directors and officers was announced.
Investors who are current long term investors inSina Corporation (formerly NASDAQ: SINA shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in Sina Corporation (formerly NASDAQ:…
More Releases for Syneos
Healthcare Rpo Market Is Going to Boom | • ICON plc • Syneos Health • Labc …
Coherent Market Insights has released a report titled "Healthcare Rpo Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast, 2026-2033", which includes market percentage records and a thorough enterprise-level analysis. This report examines competitive dynamics, regional performance, and long-term growth potential across the global market. This comprehensive study covers industry performance, critical success factors, risk assessment, manufacturing prerequisites, project costs, economic analysis, anticipated return on investment (ROI), and profit margins-making…
Bioequivalence Studies Market Rewriting Long Term Growth Story | IQVIA, Syneos H …
HTF Market Intelligence published a new research document of 150+pages on Bioequivalence Studies Market Insights, to 2033" with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Bioequivalence Studies market was mainly driven by the increasing R&D spending by leading and emerging player, however latest scenario and economic slowdown have…
Pharmaceutical Contract Sales Outsourcing Market Is Going to Boom |• IQVIA • …
Worldwide Market Reports has recently released a comprehensive research study titled "Pharmaceutical Contract Sales Outsourcing Market Size and Forecast 2026-2033: Breakdown by Manufacturers, Key Regions, Types, and Applications." The report has been developed using a combination of primary and secondary research methodologies, ensuring a detailed and accurate analysis. Drawing insights from both historical data and future projections, the study highlights the expected growth of the Pharmaceutical Contract Sales Outsourcing market…
Medical Affairs Outsourcing Market Is Going to Boom |• IQVIA • Syneos Health
Worldwide Market Reports has added a new research study on "Medical Affairs Outsourcing Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources.
The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth opportunities, development…
Bioanalytical Services Market To Witness Excellent Growth | IQVIA, Syneos Health …
HTF Market Intelligence published a new research document of 150+pages on" Bioanalytical Services Market Insights, to 2028" with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Bioanalytical Services market was mainly driven by the increasing R&D spending by leading and emerging player, however latest scenario and economic slowdown have…
Bioanalytical Services Market SWOT Analysis by Key Players- ICON, Algorithme, PR …
A new business intelligence report released by HTF MI with title "Global Bioanalytical Services Market Size, Status and Forecast 2019-2025" is designed covering micro level of analysis by manufacturers and key business segments. The Global Bioanalytical Services Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and…
